Age: 43.0
Sex: F
Vaccine: COVID19, FLU3
Symptoms: Chills, Decreased appetite, Dehydration, Diarrhoea, Fatigue
Clinical narrative: Fatique; Headache; Chills; Fever; Nausea; Decreased appetite; Substantial diarrhea; Dehydration; This is a spontaneous report received from a consumer.  A 43-year-old female patient (not pregnant) received BNT162b2 Omicron (kp.2) (COMIRNATY (2024-2025 FORMULA)), on 08Sep2024 at 13:00 as dose 1, single (Batch/Lot number: unknown) at the age of 43 years, in left arm for covid-19 immunisation; influenza vaccine rha 3v (baculovirus) (FLUBLOK), on 08Sep2024 at 01:00 as dose number unknown, single), in right arm for immunisation. The patient's relevant medical history included: "Asthma" (unspecified if ongoing); "Peanut allergy" (unspecified if ongoing); "Bees allergy" (unspecified if ongoing); "Sulfa drugs allergy" (unspecified if ongoing); "Allergies to CT contrast dye" (unspecified if ongoing). The patient had no other medications in two weeks. Past drug history included: Tessalon perle, reaction(s): "Allergies"; Isovue, reaction(s): "Allergies"; Doxycycline, reaction(s): "Allergies". The patient had no other vaccine in four weeks. The following information was reported: CHILLS (hospitalization) with onset 11Sep2024 at 22:00, outcome "recovering"; DECREASED APPETITE (hospitalization) with onset 11Sep2024 at 22:00, outcome "recovering"; DEHYDRATION (hospitalization) with onset 11Sep2024 at 22:00, outcome "recovering"; FATIGUE (hospitalization) with onset 11Sep2024 at 22:00, outcome "recovering", described as "Fatique"; PYREXIA (hospitalization) with onset 11Sep2024 at 22:00, outcome "recovering", described as "Fever"; HEADACHE (hospitalization) with onset 11Sep2024 at 22:00, outcome "recovering"; NAUSEA (hospitalization) with onset 11Sep2024 at 22:00, outcome "recovering"; DIARRHOEA (hospitalization) with onset 11Sep2024 at 22:00, outcome "recovering", described as "Substantial diarrhea". The patient was hospitalized for fatigue, headache, chills, pyrexia, nausea, decreased appetite, diarrhoea, dehydration (start date: Sep2024, discharge date: Sep2024, hospitalization duration: 1 day(s)). The events "fatique", "headache", "chills", "fever", "nausea", "decreased appetite", "substantial diarrhea" and "dehydration" required emergency room visit. 3 days after receiving the vaccines, the patient developed fatigue, headache, chills, fever, nausea, decreased appetite, and substantial diarrhea. The primary care physician didn't have any available appointments, so the patient went to urgent care. They felt it was more likely viral or bacterial and run a bunch of tests. Three days later, the patient was feeling worse, she was in the emergency room and treated for dehydration. The patient's symptoms lasted 11 days. All the testing produced negative results, hence why she and leading towards believing it was the vaccine or combination of the two together. Therapeutic measures were not taken as a result of fatigue, headache, chills, pyrexia, nausea, decreased appetite, diarrhoea. Therapeutic measures were taken as a result of dehydration.  The information on the batch/lot number for BNT162b2 omicron (kp.2) will be requested and submitted if and when received.